KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Other financing activities (2018 - 2019)

Historic Other financing activities for Adaptive Biotechnologies (ADPT) over the last 2 years, with Q3 2019 value amounting to $1.6 million.

  • Adaptive Biotechnologies' Other financing activities rose 3262000.0% to $1.6 million in Q3 2019 from the same period last year, while for Dec 2020 it was $5.0 million, marking a year-over-year increase of 12.03%. This contributed to the annual value of $321000.0 for FY2020, which is 9356.2% down from last year.
  • Per Adaptive Biotechnologies' latest filing, its Other financing activities stood at $1.6 million for Q3 2019, which was up 3262000.0% from $3.4 million recorded in Q2 2019.
  • Over the past 5 years, Adaptive Biotechnologies' Other financing activities peaked at $3.4 million during Q2 2019, and registered a low of -$6000.0 during Q1 2019.